Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
EMBC

EMBC - Embecta Corp. Stock Price, Fair Value and News

$10.20-0.20 (-1.92%)
Market Closed

40/100

EMBC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

40/100

EMBC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$9.7

Target 3M

$10.61

Target 6M

$10.31

EMBC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EMBC Price Action

Last 7 days

-17.3%

Last 30 days

-14.0%

Last 90 days

-25.3%

Trailing 12 Months

-46.3%

EMBC RSI Chart

EMBC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EMBC Valuation

Market Cap

596.8M

Price/Earnings (Trailing)

6.26

Price/Sales (Trailing)

0.55

EV/EBITDA

9.94

Price/Free Cashflow

3.27

EMBC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$9.7

Target 3M

$10.61

Target 6M

$10.31

EMBC Fundamentals

EMBC Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

-7.72%

Rev. Growth (Qtr)

-10.66%

EMBC Earnings

Earnings (TTM)

95.4M

Earnings Growth (Yr)

80.82%

Earnings Growth (Qtr)

-41.98%

EMBC Profitability

EBT Margin

12.62%

Return on Equity

-14.66%

Return on Assets

8.75%

Free Cashflow Yield

30.56%

EMBC Investor Care

Dividend Yield

5.88%

Dividend/Share (TTM)

0.6

Shares Dilution (1Y)

0.66%

Diluted EPS (TTM)

1.62

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.1B1.1B1.1B0
20241.1B1.1B1.1B1.1B
20231.1B1.1B1.1B1.1B
20221.2B1.2B1.1B1.1B
20211.1B1.1B1.2B1.2B
2020001.1B1.1B
Get all data in R, Python etc through our Historical Stock Data APIs

About Embecta Corp.

EMBC
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
 CEO
 WEBSITEembecta.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES1900

Embecta Corp. Frequently Asked Questions

EMBC is the stock ticker symbol of Embecta Corp.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Embecta Corp. is 596.83 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check EMBC's fair value in chart for subscribers.

The fair value guage provides a quick view whether EMBC is over valued or under valued. Whether Embecta Corp. is cheap or expensive depends on the assumptions which impact Embecta Corp.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EMBC.

As of Wed Jan 28 2026, EMBC's PE ratio (Price to Earnings) is 6.26 and Price to Sales (PS) ratio is 0.55. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EMBC PE ratio will change depending on the future growth rate expectations of investors.